Gilead Sciences names McCann Health Japan to launch consumer disease awareness campaign

Gilead Sciences Logo.jpgMcCann Health Japan has been appointed by Gilead Sciences to launch a significant direct to consumer disease awareness campaign to encourage people with Hepatitis C to visit their doctor.
The campaign intends to educate the public on the significant advancement in HCV therapy where patients in Japan can now aim for a cure of this chronic disease with oral treatment in as little as 12 weeks. A cure from HCV is associated with significantly reduced rates of cirrhosis, liver cancer, and death. The benefits of achieving a cure have also been associated with an increased quality of life.

With most Hepatitis C sufferers in Japan being elderly citizens who contracted the disease through no fault of their own from a tainted vaccination program in the 1950s, the outcomes of this campaign are potentially very important for Japanese patients, their families and the broader community to understand this is a disease that can be cured and eventually eliminated in Japan.

Leave a comment

About Campaign Brief Asia

A blog for advertising creatives in Asia. To pass on news or advertise on the CB Asia blog, or to subscribe to Campaign Brief Asia or Campaign Brief Australia/NZ magazines, or The Work 09 Annual, email: Kim or Michael

Latest jobs

Retrieving latest jobs

House rules for commenting

Here are the ground rules for posting comments on stories: This site is a moderated blog. Comments that are seen to be more abusive than witty and/or constructive will not be posted. Obviously, we do not allow 'hate speech' or comments that are seen as a personal attack, defamatory, degrading or prejudicial to an individual or company. Overly abusive language also adds nothing to any discussion and will not be published. On occasions we will be asking people to contribute work, opinions and views on various topics - you are free to disagree, so long as you observe the above rules and remain constructive.